Page last updated: 2024-08-24

plerixafor and ALS - Amyotrophic Lateral Sclerosis

plerixafor has been researched along with ALS - Amyotrophic Lateral Sclerosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barbiro, B; Ezra, A; Rabinovich-Nikitin, I; Rabinovich-Toidman, P; Solomon, B	1

Other Studies

1 other study(ies) available for plerixafor and ALS - Amyotrophic Lateral Sclerosis

Article	Year
Chronic administration of AMD3100 increases survival and alleviates pathology in SOD1(G93A) mice model of ALS. Journal of neuroinflammation, 2016, 05-26, Volume: 13, Issue:1 Topics: Amyotrophic Lateral Sclerosis; Animals; Benzylamines; Calcium-Binding Proteins; Chemokine CCL2; Claudin-5; Cyclams; Cytokines; Disease Models, Animal; Gene Expression Regulation; Heterocyclic Compounds; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microfilament Proteins; Motor Neurons; Muscle Strength; Psychomotor Disorders; Receptors, CXCR4; Superoxide Dismutase; Zonula Occludens-1 Protein	2016

Article

Year

Chronic administration of AMD3100 increases survival and alleviates pathology in SOD1(G93A) mice model of ALS.

Journal of neuroinflammation, 2016, 05-26, Volume: 13, Issue:1

Topics: Amyotrophic Lateral Sclerosis; Animals; Benzylamines; Calcium-Binding Proteins; Chemokine CCL2; Claudin-5; Cyclams; Cytokines; Disease Models, Animal; Gene Expression Regulation; Heterocyclic Compounds; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microfilament Proteins; Motor Neurons; Muscle Strength; Psychomotor Disorders; Receptors, CXCR4; Superoxide Dismutase; Zonula Occludens-1 Protein

2016